Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome

Clinical Toxicology

Volumn 48, Issue 8, 2010, Pages 806-812

  Engebretsen, Kristin M ^a   Morgan, Matthew W ^a   Stellpflug, Samuel J ^a   Cole, Jon B ^a   Anderson, Christopher P ^b  

^a REGIONS HOSPITAL   (United States)

^b HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

Cardiac support; Cardiovascular; HDI; Heart; Vasopressors

Indexed keywords

DIHYDROPYRIDINE; INSULIN; NIFEDIPINE; PHENYLEPHRINE; CALCIUM CHANNEL BLOCKING AGENT;

ALKALOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG OVERDOSE; HEART INDEX; HEART OUTPUT; HEART RATE; LUNG VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; MORTALITY; NONHUMAN; RESUSCITATION; SURVIVAL; SWINE; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; HEMODYNAMICS; PATHOPHYSIOLOGY; VASOCONSTRICTION;

SUS;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DRUG OVERDOSE; HEMODYNAMICS; INSULIN; NIFEDIPINE; PHENYLEPHRINE; SHOCK, CARDIOGENIC; SWINE; VASOCONSTRICTION;

EID: 77958549169     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2010.521753     Document Type: Article

References (23)

1. Bronstein AC, Spyker DA, Cantilena JR, Green JL, Rumack BH, Giffin SL. 2008 Annual report of the American Association of Poison Control Centers National Poison Data System (NPDS): 26th annual report. Clin Toxicol 2009; 47:914-1084.
2. Schoffstall JM, Spivey WH, Gambone LM, Shaw RP, Sit SP. Effects of calcium channel blocker overdose-induced toxicity in the conscious dog. Ann Emerg Med 1991; 20:1104-1108.
3. Shepherd G. High dose insulin therapy for calcium channel blocker overdose. Ann Pharmacother 2005; 39:923-930.
4. Anderson EA, Hoffman RP, Valon TW, Sinkey CA, Mark AL. Hyper-insulinemia produces both sympathetic neural activation and vasodila-tion in normal humans. J Clin Invest 1991; 87:2246-2252.
5. Crystal GJ, Kim GJ, Ramez Salem M, Abdel-Latif, M. Myocardial oxy-gen supply/demand relations during phenylephrine infusions in dogs. Anesth Analg 1991; 73:284-288.
6. Holger JS, Dries DJ, Barringer KW, Peake BJ, Flottemesch TJ, Marini JJ. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model. Acad Emerg Med 2010; 17:429-435.
7. Pocock SJ. Group sequential methods in the design and analysis of clin-ical trials. Biometrika 1977; 64:191-199.
8. Megarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and ß-blocker poisoning. Toxicol Rev 2004; 23:215-222.
9. Salhanick SD, Shannon MW. Management of calcium channel antago-nist overdose. Drug Saf 2003; 26:65-79.
10. Kerns II W, Shroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute beta blocker toxicity. Ann Emerg Med 1997; 29:748-757.
11. Kline JA, Leonova E, Raymond R. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 1995; 23:1251-1263.
12. Kline JA, Raymond RM, Leonova ED, Williams TC, Watts JA. Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines. Cardiovascular Research 1997; 34:289-298.
13. Stone CK, Thomas SH, Koury SI, Low RB. Glucagon and phenyleph-rine combination versus glucagon alone in experimental verapamil overdose. Acad Emerg Med 1996; 3:12-125.
14. Holger JS, Engebretsen, KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol 2007; 45:396-401.
15. Svedjeholm R, Hallhagen S, Ekroth R, Joachimsson PO, Ronquist G. Dopamine and high dose insulin infusion (glucose-insulin-potassium) after a cardiac operation: Effects on myocardial metabolism. Ann Thorac Surg 1991; 51:262-270.
16. Bersin RM, Stacpoole PW. Dichloroacetate as metabolic therapy for myo-cardial ischemia and failure. Am Heart J 1997; 134(5 Pt 1):841-855.
17. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 2004;147:91-99.
18. Bellomo R, Wam L, May C. Vasoactive drugs and acute kidney injury. Crit Care Med 2008; 36:S179-S186. (Pubitemid 351483049)
19. Clerk LH, Vincent MA, Lindner JR, Clark MG, Rattigan S, Barrett E. The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabetes Metab Res Rev 2004; 20:3-12.
20. Leppikangas H, Ruokonen E, Rutanen J, Kivinemi V, Lindgren L, Kurola J. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: A randomized study. Ann Emerg Med 2009; 54:811-817.
21. Jamatay C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid emulsions in the treatment of acute poisoning: A systematic review of human and animal studies. Clin Toxicol 2010; 48:1-27.
22. Bania T, Chu J, Perez E, Medlej K, Rosselli M, Mouravev R, Yang J, Lee D. Hemodynamic effects of intravenous fat emulsion versus high dose insulin euglycemia in a model of severe verapamil toxicity. Acad Emerg Med 2008; 15(5 Suppl. 1):S93.
23. Chu J, Medlej K, Bania T, Perez E, Mouravev R. The effect of intrave-nous fat emulsions in nifedipine toxicity. Acad Emerg Med 2009; 16:S226.